S3206 Primary Squamous Cell Carcinoma of the Pancreas Presenting With Obstructive Jaundice: A Rare Case Report

Introduction: Primary squamous cell carcinoma (SCC) of the pancreas is an extremely rare malignancy, accounting for less than 1% of all pancreatic cancers. The pancreas lacks native squamous epithelium, and diagnosis requires exclusion of metastatic disease. Due to its aggressive nature and limited therapeutic options, pancreatic SCC has a poor prognosis. This case highlights diagnostic and management considerations for this rare entity. Case Description/Methods: A 62-year-old woman with a history of alcohol use presented with progressive jaundice, dark urine, and pruritus. Laboratory evaluation showed a total bilirubin of 8.5 mg/dL and elevated ALP and GGT. Imaging revealed a pancreatic head mass with biliary obstruction. Endoscopic retrograde cholangiopancreatography (ERCP) showed a distal common bile duct stricture, requiring stent placement. Magnetic resonance cholangiopancreatorgraphy (MRCP) and magnetic resonance imaging confirmed a mass in the pancreatic head with peripancreatic lymphadenopathy and possible vascular invasion. Endoscopic ultrasound revealed a heterogeneous hypoechoic mass in the head of the pancreas measuring 4 cm with features suggestive of malignancy. Fine needle aspiration biopsies reveal infiltrating sheets of polygonal cells with intercellular bridges, eosinophilic cytoplasm, pleomorphic nuclei with prominent nucleoli, keratinization, and increased mitotic activity. Immunohistochemistry was positive for CK5/6 and p40, and negative for neuroendocrine and GI markers, confirming a diagnosis of primary pancreatic SCC, and SCC of other sites was clinically and radiologically ruled out. Extensive imaging and endoscopic evaluation ruled out other primary sites. Due to vascular invasion and nodal involvement, the disease was deemed unresectable. The patient declined chemotherapy and opted for palliative care. She underwent successful biliary decompression and celiac plexus block for pain control and was transitioned to hospice. Discussion: Primary SCC of the pancreas is a diagnosis of exclusion, requiring comprehensive imaging and histopathological confirmation. The pathogenesis remains unclear but may involve squamous metaplasia or progenitor cell transformation. Prognosis is poor, especially in unresectable cases. Surgical resection offers the best chance at survival, but most patients present with advanced disease. This case illustrates the need for early recognition, the role of EUS-FNA in diagnosis, and the importance of aligning treatment with patient goals in rare pancreatic malignancies.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001140284.14661.74
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S3206 Primary Squamous Cell Carcinoma of the Pancreas Presenting With Obstructive Jaundice: A Rare Case Report

Gloria Erazo, Zeyad Elharabi, Hakan Akın, Asad Ullah et al.
The American Journal of Gastroenterology
Pancreatic and Hepatic Oncology Research
article

S3206 Primary Squamous Cell Carcinoma of the Pancreas Presenting With Obstructive Jaundice: A Rare Case Report

Gloria Erazo, Zeyad Elharabi, Hakan Akın, Asad Ullah, Kanak Das, Khawaja Hassam, Saiyeeda Tahrima, Romelia A. Barba Bernal, Haley Lewsey
article en

Abstract

Introduction: Primary squamous cell carcinoma (SCC) of the pancreas is an extremely rare malignancy, accounting for less than 1% of all pancreatic cancers. The pancreas lacks native squamous epithelium, and diagnosis requires exclusion of metastatic disease. Due to its aggressive nature and limited therapeutic options, pancreatic SCC has a poor prognosis. This case highlights diagnostic and management considerations for this rare entity. Case Description/Methods: A 62-year-old woman with a history of alcohol use presented with progressive jaundice, dark urine, and pruritus. Laboratory evaluation showed a total bilirubin of 8.5 mg/dL and elevated ALP and GGT. Imaging revealed a pancreatic head mass with biliary obstruction. Endoscopic retrograde cholangiopancreatography (ERCP) showed a distal common bile duct stricture, requiring stent placement. Magnetic resonance cholangiopancreatorgraphy (MRCP) and magnetic resonance imaging confirmed a mass in the pancreatic head with peripancreatic lymphadenopathy and possible vascular invasion. Endoscopic ultrasound revealed a heterogeneous hypoechoic mass in the head of the pancreas measuring 4 cm with features suggestive of malignancy. Fine needle aspiration biopsies reveal infiltrating sheets of polygonal cells with intercellular bridges, eosinophilic cytoplasm, pleomorphic nuclei with prominent nucleoli, keratinization, and increased mitotic activity. Immunohistochemistry was positive for CK5/6 and p40, and negative for neuroendocrine and GI markers, confirming a diagnosis of primary pancreatic SCC, and SCC of other sites was clinically and radiologically ruled out. Extensive imaging and endoscopic evaluation ruled out other primary sites. Due to vascular invasion and nodal involvement, the disease was deemed unresectable. The patient declined chemotherapy and opted for palliative care. She underwent successful biliary decompression and celiac plexus block for pain control and was transitioned to hospice. Discussion: Primary SCC of the pancreas is a diagnosis of exclusion, requiring comprehensive imaging and histopathological confirmation. The pathogenesis remains unclear but may involve squamous metaplasia or progenitor cell transformation. Prognosis is poor, especially in unresectable cases. Surgical resection offers the best chance at survival, but most patients present with advanced disease. This case illustrates the need for early recognition, the role of EUS-FNA in diagnosis, and the importance of aligning treatment with patient goals in rare pancreatic malignancies.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 45%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.